A coordinated multi-target approach based on chondroitin sulphate nano-selenium mitigates Alzheimer’s disease pathologies in APP/PS1 mice
Dongsheng Ji, Jing Zhao, Xinhui Huang, Xuan Liu, Qirong Yang, Xinfeng Li, Lei Yan, Debo Gao, Yuliang Xiao · 2026
Read A coordinated multi-target approach based on chondroitin sulphate nano-selenium mitigates Alzheimer’s disease pathologies in APP/PS1 mice by Dongsheng Ji, Jing Zhao, Xinhui Huang, Xuan Liu, Qirong Yang, Xinfeng Li, Lei Yan, Debo Gao, Yuliang Xiao (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13619492.txt.
Description
Dongsheng Ji and eight co-authors report a 2026 study of a selenium-based compound tested in mice bred to develop Alzheimer's-like disease. The illness brings steady memory loss, and no strong treatment exists, so new options are in demand. The compound joins selenium particles with a sugar-like substance found in cartilage.
Treated mice learned and remembered better in behavior tests and moved more than untreated ones. In the brain, the compound raised levels of an enzyme that cuts the amyloid source protein in a safe way, and lowered the enzyme that cuts it in the harmful way. Harmful deposits fell, a second damage marker eased, and signs of stress, swelling, and nerve signal loss all improved. The authors read this as proof that one agent can hit several disease paths at once.
Catalog record
| CREATOR | Dongsheng Ji, Jing Zhao, Xinhui Huang, Xuan Liu, Qirong Yang, Xinfeng Li, Lei Yan, Debo Gao, Yuliang Xiao |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |